Daily News Podcast

Benzodiazepines double risk of suicide among COPD patients


 

Patients with chronic obstructive pulmonary disease who are taking benzodiazepines have more than double the risk of suicide compared with patients who are not on those medications. Also today, the feds say that the ACA’s silver plan premiums will drop in 2019, bias in the clinical setting can impact patient care, and managing asthma in children mean that pets do not always have to go.

The Postcall Podcast is available here: https://www.mdedge.com/podcasts

Recommended Reading

Neurological disease and aging
MDedge Rheumatology
PCV13 for older adults
MDedge Rheumatology
Sexual assault, harassment linked to depression
MDedge Rheumatology
How to vaccinate patients on biologics
MDedge Rheumatology
Allopurinol reduces risk of renal decline in gout patients
MDedge Rheumatology
9-valent HPV vaccine approved for 27-45 age group
MDedge Rheumatology
Outpatients antibiotics and disease codes
MDedge Rheumatology
Bisphosphonate holiday reduces risk of atypical femur fracture
MDedge Rheumatology
Patient-centered guidelines for type 2 diabetes
MDedge Rheumatology
DOACs cut mortality
MDedge Rheumatology